Viewing StudyNCT00250367



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00250367
Status: COMPLETED
Last Update Posted: 2010-11-25
First Post: 2005-11-04

Brief Title: A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
Sponsor: Janssen Pharmaceutica NV Belgium
Organization: Janssen Pharmaceutica NV Belgium

Organization Data

Organization: Janssen Pharmaceutica NV Belgium
Class: INDUSTRY
Study ID: CR006058
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Janssen Pharmaceutica NV Belgium
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators